Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
1,320,778
-
Shares change
-
+270,964
-
Total reported value, excl. options
-
$7,145,290
-
Value change
-
+$1,393,789
-
Number of buys
-
19
-
Number of sells
-
-15
-
Price
-
$5.41
Significant Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q4 2024
38 filings reported holding NVCT - Nuvectis Pharma, Inc. - COM as of Q4 2024.
Nuvectis Pharma, Inc. - COM (NVCT) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,320,778 shares
.
Largest 10 shareholders include BALDWIN WEALTH PARTNERS LLC/MA (355,961 shares), VANGUARD GROUP INC (325,297 shares), MARSHALL WACE, LLP (124,571 shares), GEODE CAPITAL MANAGEMENT, LLC (79,243 shares), BlackRock, Inc. (62,342 shares), FORBES J M & CO LLP (59,000 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (45,607 shares), GSA CAPITAL PARTNERS LLP (34,751 shares), Qube Research & Technologies Ltd (30,594 shares), and MILLENNIUM MANAGEMENT LLC (29,698 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.